ArticleBMC psychiatry2016

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.

Jean Lachaine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.